Hu S - Search Results

1

Reliability and validity of the functional assessment of cancer therapy-ovarian.

Basen-Engquist K, Bodurka-Bevers D, Fitzgerald MA, Webster K, Cella D, Hu S, Gershenson DM. Basen-Engquist K, et al. Among authors: hu s. J Clin Oncol. 2001 Mar 15;19(6):1809-17. doi: 10.1200/JCO.2001.19.6.1809. J Clin Oncol. 2001. PMID: 11251013

2

Switch Control Inhibition of KIT and PDGFRA in Patients With Advanced Gastrointestinal Stromal Tumor: A Phase I Study of Ripretinib.

Janku F, Abdul Razak AR, Chi P, Heinrich MC, von Mehren M, Jones RL, Ganjoo K, Trent J, Gelderblom H, Somaiah N, Hu S, Rosen O, Su Y, Ruiz-Soto R, Gordon M, George S. Janku F, et al. Among authors: hu s. J Clin Oncol. 2020 Oct 1;38(28):3294-3303. doi: 10.1200/JCO.20.00522. Epub 2020 Aug 17. J Clin Oncol. 2020. PMID: 32804590 Free PMC article. Clinical Trial.

3

Phase I study of pemetrexed and pegylated liposomal doxorubicin in patients with refractory breast, ovarian, primary peritoneal, or fallopian tube cancer.

Richards DA, Loesch D, Vukelja SJ, Wu H, Hyman WJ, Nieves J, Wang Y, Hu S, Shonukan OO, Tai DF. Richards DA, et al. Among authors: hu s. Invest New Drugs. 2011 Oct;29(5):963-70. doi: 10.1007/s10637-010-9414-6. Epub 2010 Mar 30. Invest New Drugs. 2011. PMID: 20352294 Clinical Trial.

4

Differential clinical and prognostic impact of myeloid sarcoma vs medullary myeloid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy.

Chen Z, Wang W, Cortes JE, Liu E, Miranda RN, Zhao C, Yuan J, Lu X, Yang W, Ameri MD, Kantarjian HM, Medeiros LJ, Hu S. Chen Z, et al. Among authors: hu s. Blood Cancer J. 2016 May 6;6(5):e418. doi: 10.1038/bcj.2016.27. Blood Cancer J. 2016. PMID: 27152845 Free PMC article. No abstract available.

5

Cytogenetic landscape and impact in blast phase of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy.

Chen Z, Shao C, Wang W, Zuo Z, Mou X, Hu SJ, DiGiuseppe JA, Zu Y, Medeiros LJ, Hu S. Chen Z, et al. Among authors: hu s, hu sj. Leukemia. 2017 Mar;31(3):585-592. doi: 10.1038/leu.2016.231. Epub 2016 Aug 18. Leukemia. 2017. PMID: 27560111

6

Differential impact of additional chromosomal abnormalities in myeloid vs lymphoid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy.

Chen Z, Cortes JE, Jorgensen JL, Wang W, Yin CC, You MJ, Jabbour E, Kantarjian HM, Medeiros LJ, Hu S. Chen Z, et al. Among authors: hu s. Leukemia. 2016 Jul;30(7):1606-9. doi: 10.1038/leu.2016.6. Epub 2016 Feb 3. Leukemia. 2016. PMID: 26837843 Free PMC article. No abstract available.

7

T-lymphoid or T/myeloid blast phase of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy: a report of 14 cases.

Gong Z, Xie W, Wang W, Chen Z, Xu J, Yuan J, Zhou Y, Wang D, Medeiros LJ, Hu S. Gong Z, et al. Among authors: hu s. Int J Lab Hematol. 2017 Apr;39(2):e45-e50. doi: 10.1111/ijlh.12605. Epub 2016 Nov 13. Int J Lab Hematol. 2017. PMID: 27863007 No abstract available.

8

Chronic myelogenous leukemia in patients with MPL or JAK2 mutation-positive myeloproliferative neoplasm.

Chen Z, Wang W, Verstovsek S, Cortes JE, Medeiros LJ, Hu S. Chen Z, et al. Among authors: hu s. Int J Lab Hematol. 2015 Dec;37(6):e150-2. doi: 10.1111/ijlh.12398. Epub 2015 Jun 18. Int J Lab Hematol. 2015. PMID: 26086872 No abstract available.

9

Impact of trisomy 8 on treatment response and survival of patients with chronic myelogenous leukemia in the era of tyrosine kinase inhibitors.

Wang W, Cortes JE, Lin P, Khoury JD, Ai D, Tang Z, Tang G, Jorgensen JL, Medeiros LJ, Hu S. Wang W, et al. Among authors: hu s. Leukemia. 2015 Nov;29(11):2263-6. doi: 10.1038/leu.2015.96. Epub 2015 Apr 14. Leukemia. 2015. PMID: 25931274 No abstract available.

10

Differential depth of treatment response required for optimal outcome in patients with blast phase versus chronic phase of chronic myeloid leukemia.

Chen Z, Medeiros LJ, Kantajian HM, Zheng L, Gong Z, Patel KP, Xiong H, Wang W, Cortes JE, Hu S. Chen Z, et al. Among authors: hu s. Blood Cancer J. 2017 Feb 3;7(2):e521. doi: 10.1038/bcj.2017.4. Blood Cancer J. 2017. PMID: 28157214 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17,471 results

Search Page